Squarepoint
AMED

Squarepoint’s Amedisys AMED Stock Holding History

Squarepoint’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,937
Closed -$486K – 4330
2025
Q2 		$486K Sell
4,937
-112,880
-96% -$10.7M ﹤0.01% 3307
2025
Q1 		$10.9M Sell
117,817
-68,562
-37% -$6.32M 0.01% 979
2024
Q4 		$16.9M Buy
186,379
+4,158
+2% +$382K 0.02% 862
2024
Q3 		$17.6M Buy
182,221
+117,274
+181% +$11.4M 0.03% 653
2024
Q2 		$5.96M Buy
64,947
+27,353
+73% +$2.54M 0.01% 1253
2024
Q1 		$3.46M Buy
37,594
+8,335
+28% +$781K 0.01% 1716
2023
Q4 		$2.78M Buy
29,259
+19,855
+211% +$1.85M 0.01% 1785
2023
Q3 		$878K Sell
9,404
-18,217
-66% -$1.68M ﹤0.01% 2421
2023
Q2 		$2.53M Sell
27,621
-10,077
-27% -$827K 0.01% 1513
2023
Q1 		$2.77M Buy
37,698
+23,678
+169% +$2.05M 0.01% 1216
2022
Q4 		$1.17M Buy
14,020
+10,640
+315% +$959K ﹤0.01% 1714
2022
Q3 		$327K Sell
3,380
-10,940
-76% -$1.3M ﹤0.01% 2433
2022
Q2 		$1.5M Buy
14,320
+12,563
+715% +$1.61M 0.01% 1359
2022
Q1 		$303K Buy
+1,757
New +$262K ﹤0.01% 2269
2021
Q4 		– Sell
-40,417
Closed -$6.03M – 3130
2021
Q3 		$6.03M Buy
40,417
+35,076
+657% +$7.29M 0.02% 693
2021
Q2 		$1.31M Buy
+5,341
New +$1.4M 0.01% 1441
2021
Q1 		– Sell
-939
Closed -$275K – 3067
2020
Q4 		$275K Sell
939
-28,345
-97% -$7.27M ﹤0.01% 2272
2020
Q3 		$6.92M Buy
29,284
+6,268
+27% +$1.43M 0.09% 257
2020
Q2 		$4.57M Buy
23,016
+19,430
+542% +$3.62M 0.07% 362
2020
Q1 		$658K Sell
3,586
-13,345
-79% -$2.37M 0.02% 901
2019
Q4 		$2.83M Sell
16,931
-15,666
-48% -$2.33M 0.02% 712
2019
Q3 		$4.27M Buy
32,597
+1,296
+4% +$169K 0.04% 536
2019
Q2 		$3.8M Sell
31,301
-63,552
-67% -$7.54M 0.04% 545
2019
Q1 		$11.7M Buy
94,853
+80,878
+579% +$10.2M 0.12% 197
2018
Q4 		$1.64M Buy
13,975
+9,553
+216% +$1.13M 0.02% 745
2018
Q3 		$553K Sell
4,422
-1,232
-22% -$136K 0.01% 1252
2018
Q2 		$483K Buy
+5,654
New +$415K 0.01% 1205
2018
Q1 		– Sell
-32,126
Closed -$1.69M – 1656
2017
Q4 		$1.69M Buy
+32,126
New +$1.69M 0.03% 621
2016
Q3 		– Sell
-7,056
Closed -$356K – 997
2016
Q2 		$356K Sell
7,056
-6,200
-47% -$313K 0.02% 666
2016
Q1 		$641K Buy
+13,256
New +$511K 0.05% 524

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Squarepoint's AMED Position: Q3 2025 in Review

Squarepoint sold out of Amedisys (AMED) in Q3 2025, closing a stake of 4,937 shares — an estimated $486K sold.

Squarepoint first reported a position in AMED in Q1 2016 and held it in 30 quarters. The position peaked at $17.6M in Q3 2024. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Squarepoint reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Squarepoint sold 4,937 Amedisys shares in Q3 2025, an estimated $486K.
  • Squarepoint first reported a position in Amedisys in Q1 2016 and held it in 30 quarters.
  • Squarepoint's Amedisys position peaked at $17.6M in Q3 2024.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Squarepoint's 13F filing for Q3 2025, filed 14 Nov 2025.